Exchange: NASDAQ·Updated 10:42 AM EDT
IMNN logo

IMNN Imunon Inc

$1.27
$0.0101
(0.79%)
Today
Mkt Cap$7.18M
Vol13,113.00

About IMNN

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
32

Bearish Sentiment

How do you feel about IMNN?

TheManUpstairs
DCAing $IMNN regularly. Just a few more buys left to fill my starter position. From there, I’d love to see either a non-dilutive ex-US partnership — where I’d resume accumulating — or a new financing that tanks the price, allowing me to deploy heavy dry powder at a deep discount. Beyond the remarkable efficacy signal and OS benefit, the safety profile looks increasingly de-risked (September IDMC review). Tons of catalysts ahead — enrollment acceleration, the 80-patient milestone in Q1 2027, a potential non-dilutive ex-US partnership, and eventually the first interim efficacy readout. oversold $IMNN means
1
3
ConcernedCitizen23
$IMNN the news on the phase 2 trial is absolutely amazing. This company hasn’t been acquired because of toxicity concerns. They have shown over and over again there is no significant toxicity at all. Compare that to chemo
6
Aawilliam2003
$IMNN $8 million market cap seems ridiculous for where they are. Ithink a reset to $150 million would be pretty rational
3
bxp2390
$IMNN I did not like the debt financing with Streeterville given their somewhat toxic financing history for other stocks. But just saw IDAI, another company they did debt financing for in June which has tripled in value so all is not bad. The issue with Imunon appears to be more to do with lack of faith in the management from executing any high value partnership. That's why even on seemingly good news days this stock struggles to tack on ten cents.
3
bomber1
$IMNN This share price shows a lack of respect for shareholders because it is blatantly controlled and manipulated; there are only two possibilities: either they have nothing in hand—meaning it is all just press releases—or they have something major but do not want the share price to rise. In either case, the management's behavior is improper—to put it mildly—and they have been acting this way for 50 years.
3
ConcernedCitizen23
$IMNN funny thing happened after the ceo and executive team started getting paid in common stock…dilution of the common stock stopped…wow amazing
2
bxp2390
$IMNN The market cap case can be made stronger, the closer this gets to P3 progress. Again, when P2 results were announced the market cap hit $100 million. But as long as we need to fund trials with stock, downward pressure exists. At some point you hope it will meet an upward move that pushes it to valuation of a P3 nearing completion. Oh well.
2
LKDOG
$IMNN “MRNA stock rallied more than 12% after it said that its Phase 3 results for personalized cancer therapy will be presented at the ESMO Congress 2026. “
2
LKDOG
$IMNN Anticipate that we will see a very similar trajectory as MRNA …very soon ! Backing the truck up !!!
2
bxp2390
$IMNN What we're seeing here now is the result of repeated colossal failures from this management. Repeated saying that P3 could be funded by partnerships until recently and then not delivering any. Looks like the only partnerships they can pull off are ones with wall street bankers adept at making money off of retail investors like many of us who end up losing our shirts.
2
bomber1
$IMNN Nice opening! Will it get above a dollar by Christmas? No, I’ll ask Citizen, who’s daydreaming—he’s the one with the inside info.
1
bomber1
$IMNN It’s unbelievable—down another 5% today. There hasn't been a single stretch of two or three consecutive days in 2026 where the stock has gone up! It just can't seem to stay on its feet.
1
BA777
$IMNN They need to raise/dilute $30 Million, minimum, over the next 4 years. Not to mention what steps they'll need to take to keep in compliance. If this comp[any has such a great drug, a 5x current price buyout = 36M. That's less than chump change for BP. For some reason it doesn't seem very appealing to them.😕
Aawilliam2003
$IMNN question for jjegglie. So your claim is that $IMNN is a scam that produced fake data by cherry picking patients? And that all pharma that have looked at their data quickly realized it was all a scam. So if this is true, why is the FDA allowing them to run a phase 3 which is just another huge scam doing real damage to very ill women? Where are the citizens petitions like we saw with Cassava? Is Stacy just a purely evil person who knows all of this but has chosen to give false hope to women across the country? Where is your info coming from? I’m not doubting you or calling you an idiot- I am a humble person but really am curious where your insights come from
jjegglie
$IMNN $IMNN We'll take run #1,000,001 at this. What legitimate drug company would partner with a firm which could simply be purchased in whole for the funds in petty cash? Still waiting for the answer to this question. Been asking it for years now.
RaKa82
$IMNN they need to say something because this is not trending well. Need some good content and commentary in next week’s R&D day

Advertisement|Remove ads.